Aethlon Medical Inc
AEMD
Company Profile
Business description
Aethlon Medical Inc is a medical therapeutic company. The company is focused on addressing unmet needs in health and biodefense. The company is focused on the development of Hemopurifier, a clinical-stage therapeutic device designed to combat cancer and eliminate life-threatening viruses from the circulatory system.
Contact
11555 Sorrento Valley Road
Suite 203
San DiegoCA92121
USAT: +1 619 941-0360
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 March 2025
Employees
14
Stocks News & Analysis
stocks
Best and worst performing ASX sectors of 2024
Exploring the ASX sectors that moved the market this year.
stocks
2 ASX companies with the traits of a long-term winner
Two companies that show promising signs of handsomely rewarding shareholders.
video
Our outlook for 2025
Morningstar Equity Market Strategist Lochlan Halloway discusses his view on what we can expect in markets in 2025.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,465.00 | 44.50 | 0.53% |
| CAC 40 | 7,379.40 | 1.34 | -0.02% |
| DAX 40 | 19,985.54 | 76.40 | 0.38% |
| Dow JONES (US) | 42,844.31 | 300.09 | 0.71% |
| FTSE 100 | 8,256.00 | 82.98 | 1.02% |
| HKSE | 19,623.32 | 436.63 | -2.18% |
| NASDAQ | 19,475.97 | 165.18 | 0.86% |
| Nikkei 225 | 39,894.54 | 386.62 | -0.96% |
| NZX 50 Index | 13,110.74 | 159.27 | -1.20% |
| S&P 500 | 5,925.40 | 43.77 | 0.74% |
| S&P/ASX 200 | 8,201.20 | 42.10 | 0.52% |
| SSE Composite Index | 3,262.56 | 89.20 | -2.66% |